Results 251 to 260 of about 12,937,092 (315)
Modular, focused data science education improves biomedical learners' abilities: A study of the Data and Analytics for Research Training (DART) program. [PDF]
Hartman R+6 more
europepmc +1 more source
The Multi-angle Imaging SpectroRadiometer science data system, its products, tools, and performance
G.W. Bothwell+3 more
openalex +1 more source
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef+10 more
wiley +1 more source
Big Data Science on T Cell Receptor-mediated Immune Regulation. [PDF]
Ishigaki K.
europepmc +1 more source
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
Japan-Medical Image Database (J-MID): Medical Big Data Supporting Data Science. [PDF]
Akashi T+10 more
europepmc +1 more source
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo+11 more
wiley +1 more source
Advancing Ethical Considerations for Data Science in Injury and Violence Prevention. [PDF]
Idaikkadar N+9 more
europepmc +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source